arginyl-glycyl-aspartyl-serine has been researched along with Disease Models, Animal in 7 studies
*Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Lin, N; Peng, S; Wang, C; Zhao, M | 1 |
Guan, L; Li, Y; Liu, L; Mu, Y; Wang, C; Yan, X | 1 |
Armstead, WM; Cines, DB; Higazi, AA; Kiessling, JW | 1 |
Hah, JS; Han, JR; Kang, JL; Moon, C; Park, HJ | 1 |
Bos, IS; Dekkers, BG; Gosens, R; Halayko, AJ; Meurs, H; Zaagsma, J | 1 |
Gibbons, DL; Gill, BJ; Kurie, JM; Rizvi, ZH; Roudsari, LC; Roybal, JD; Saik, JE; West, JL | 1 |
Bernard, A; Makgoba, MW; Sanders, ME | 1 |
1 review(s) available for arginyl-glycyl-aspartyl-serine and Disease Models, Animal
Article | Year |
---|---|
Cell adhesion/signalling: biology and clinical applications.
Topics: Amino Acid Sequence; Animals; Cell Adhesion; Cell Adhesion Molecules; Disease Models, Animal; Humans; Molecular Sequence Data; Oligopeptides; Signal Transduction | 1992 |
6 other study(ies) available for arginyl-glycyl-aspartyl-serine and Disease Models, Animal
Article | Year |
---|---|
Synthesis and antithrombotic activity of carbolinecarboxyl RGD sequence.
Topics: Animals; Carbolines; Cell Adhesion; Disease Models, Animal; Fibrinolytic Agents; Humans; Male; Oligopeptides; Platelet Aggregation; Rabbits; Rats; Rats, Wistar; Structure-Activity Relationship; Thrombosis; Tumor Cells, Cultured | 2002 |
A thrombolytic therapy using diagnostic ultrasound combined with RGDS-targeted microbubbles and urokinase in a rabbit model.
Topics: Animals; Blood Platelets; Contrast Media; Disease Models, Animal; Female; Femoral Artery; Male; Microbubbles; Muscle, Skeletal; Oligopeptides; Particle Size; Rabbits; Regional Blood Flow; Thrombolytic Therapy; Thromboplastin; Ultrasonography; Urokinase-Type Plasminogen Activator; von Willebrand Factor | 2020 |
Inhibition of integrin alphavbeta3 prevents urokinase plasminogen activator-mediated impairment of cerebrovasodilation after cerebral hypoxia/ischemia.
Topics: Adrenergic beta-Agonists; Animals; Animals, Newborn; Antibodies; Cerebrovascular Circulation; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hypercapnia; Hypotension; Hypoxia-Ischemia, Brain; Integrin alphaVbeta3; Isoproterenol; Male; Oligopeptides; Peptides; Peptides, Cyclic; Signal Transduction; Swine; Urokinase-Type Plasminogen Activator; Vasoconstriction; Vasodilation | 2009 |
Synthetic RGDS peptide attenuates lipopolysaccharide-induced pulmonary inflammation by inhibiting integrin signaled MAP kinase pathways.
Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; Chemokine CXCL2; Chemotaxis; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Focal Adhesion Kinase 1; Inflammation Mediators; Integrin alphaVbeta3; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Lung; Macrophages; Male; MAP Kinase Signaling System; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Neutrophil Infiltration; Oligopeptides; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pneumonia; Time Factors; Tumor Necrosis Factor-alpha | 2009 |
The integrin-blocking peptide RGDS inhibits airway smooth muscle remodeling in a guinea pig model of allergic asthma.
Topics: Administration, Topical; Airway Remodeling; Animals; Antibodies; Asthma; Biomarkers; Blotting, Western; Cell Culture Techniques; Cell Proliferation; Disease Models, Animal; Fibrosis; Guinea Pigs; Humans; Inflammation; Male; Muscle Contraction; Muscle, Smooth; Oligopeptides; Platelet Aggregation Inhibitors; Proliferating Cell Nuclear Antigen | 2010 |
A synthetic matrix with independently tunable biochemistry and mechanical properties to study epithelial morphogenesis and EMT in a lung adenocarcinoma model.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Cell Culture Techniques; Cell Line, Tumor; Disease Models, Animal; Epithelial Cells; Epithelial-Mesenchymal Transition; Extracellular Matrix; Genes, p53; Genes, ras; Hydrogels; Lung Neoplasms; Mice; Mutation; Oligopeptides; Polyethylene Glycols | 2012 |